Blog
Telehealth marketing, ad compliance, and the growth economics underneath both. Written by a physician who works in the category, not about it.
-
Telehealth marketing terms, defined by a physician who runs the ads
Every term agencies, platforms, and regulators will throw at you, defined in one clear sentence, plus what operators get wrong about each. Definitions are free everywhere; the failure modes are what cost money.
Read → -
LegitScript certification: cost, timeline, and whether you need it
$975 to apply, $2,150 a year, and no timeline promised, all from LegitScript's own pages. What certification actually clears, what it costs after compliance trouble, and the one thing it does not do.
Read → -
Pre-prescription churn: why patients leave before treatment starts
Patients who sign up and vanish before their first prescription aren't one problem. They're four, and two of them can't be fixed by marketing. A physician on telling them apart.
Read → -
What does it actually cost to acquire a telehealth patient?
Hims spent $798.5M on acquisition in 2025 and added 282,000 net subscribers. The cost of adding one has quadrupled since 2023 — and the most-quoted CAC benchmarks aren't computable from the filings they cite.
Read → -
Where the cheap telehealth patients actually come from
The cheapest patients never touch an ad auction. Distribution comes in layers: owned, earned, and borrowed — and the order you build them in decides what paid ads cost you later.
Read → -
What you actually need to start a telehealth practice
Most founders buy the stack before the patients. What is actually load-bearing on day one, what can wait, and the licensure math nobody does out loud.
Read → -
Fractional CMO for telehealth: who should actually hire one?
A fractional CMO fits a telehealth company with revenue, a working offer, and no senior owner of growth decisions. The argument for the seat is what the other half of the week is made of.
Read → -
Your agency says they can hash the patient data. Can they?
No. The FTC titled a post “No, hashing still doesn't make your data anonymous.” What hashing actually does, and the funnel design that works instead.
Read → -
Utah told an AI to stop refilling prescriptions. The product was the problem.
Utah's medical board recommended suspending an AI refill pilot. Regulatory alignment is a launch input, not a legal review at the end.
Read → -
Can you use your own patient outcomes in your marketing?
Your outcomes data is the one asset a competitor cannot copy. The denominator is how you lose it. What the FTC requires, and a worked example.
Read → -
Telehealth advertising compliance: the seven patterns every referee keeps flagging
The FDA issued 30 warning letters in one day and reduced all thirty to two violations. Four referees, seven repeating patterns, every one quoted in a public document. Includes a tool that reads your own copy against the list.
Read → -
2026 Telehealth Marketing Budget: How Much Should a Practice Spend?
A percentage of last year's revenue cannot see a price anchor collapsing. Build the budget from patient capacity and the acquisition cost your margin can actually carry, then cap it by cash.
Read → -
Can we use Meta or Google Analytics pixels without violating HIPAA?
The line gets crossed the moment an identifier attaches to a signal about what care someone wants. Where that happens moves with your architecture, and it is almost never where the growth team thinks.
Read → -
Should we hire a healthcare growth agency or build in-house?
The bottleneck decides the team. And the thing an outside agency almost never asks about is the most important part of your intake: who you cannot see, and what happens in the sixty seconds after you tell them.
Read → -
Why does retention drop off a cliff after month 2?
The most common month-two exit is not clinical. Patients quit because they have not lost weight, when the first month's dose was never going to do that. Nobody told them. That is a marketing failure, not a churn problem.
Read → -
Why is my CAC going up every month even though nothing else changed?
A higher CAC is a finding, not a cause. Four different problems end at the same number, and they belong to four different owners. Find the first rate that broke before you touch the ads.
Read → -
How do we differentiate when every competitor claims the same convenience?
Convenience and price are unstable claims. A manufacturer agreement or a federal program can reprice your entire position overnight. Continuity is not the same face. It means the patient never starts over.
Read → -
Balancing a serious medical provider with an approachable consumer brand
Texas and California now regulate what your AI intake is allowed to sound like. But the seam you should worry about is not consumer-to-clinical. It is doctor-to-doctor.
Read → -
Before and After: 6 FDA-Flagged GLP-1 Ads, Rewritten
Six public FDA warning letter examples from GLP-1 telehealth advertising, with the flagged copy, the pattern FDA called out, and a cleaner rewrite operators can study.
Read →